FDA Approved: GEMTESA — Supplemental Application (Sumitomo Pharma America, Inc.)

View source ↗

Summary

FDA approved a supplemental application for GEMTESA (vibegron) submitted by Sumitomo Pharma America, Inc., resulting in updated labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• GEMTESA (VIBEGRON)

Snippet

SUPPL AP for GEMTESA (VIBEGRON)